RPE di Ayala Pharmaceuticals Inc. è $11.111k
I ricavi per dipendente (RPE) sono entrate divise per il numero di dipendenti di un'organizzazione.
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.